Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-19T04:35:00.167Z Has data issue: false hasContentIssue false
  • English
  • Français

Antibiotic-Resistant Bacteria and Healthcare Systems: Four Steps for Effective Response

Published online by Cambridge University Press:  02 January 2015

John E. McGowan Jr
John E. McGowan Jr*
Affiliation:
Emory University Schools of Medicine and Public Health and Grady Memorial Hospital, Atlanta, Georgia
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Infection Control & Hospital Epidemiology , Volume 16 , Issue 2 , February 1995 , pp. 67 - 70
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1995

References

1.Murray, BE. Can antibiotic resistance be controlled? N Engl J Med 1994;330:1229–1230.CrossRefGoogle ScholarPubMed
2.Tomasz, A. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University workshop. N Engl J Med 1994;330:1247–1251.CrossRefGoogle ScholarPubMed
3.Kunin, CM. Resistance to antimicrobial drugs-a worldwide calamity. Ann Intern Med 1993;118:557–561.Google Scholar
4.SB. The Antibiotic Paradox. How Miracle Drugs Are Destroying the Miracle. New York, NY: Plenum Press; 1992.Google Scholar
5.Go, ES, Urban, C, Bums, J, et al.Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymixin B and sulbactam. Lancet 1994;344:1329–1332.CrossRefGoogle Scholar
6.Iglehart, JK. Health policy report: the struggle between managed care and fee-for-service practice. N Engl J Med 1994;331:63–67.CrossRefGoogle Scholar
7.Preston, R. The Hot Zone. New York, NY: Random House; 1994.Google Scholar
8.Woolf, SH. Practice guidelines: a new reality in medicine. Arch Intern Med 1993;153:2646–2655.CrossRefGoogle ScholarPubMed
9.Gross, PA, Barrett, TL, Dellinger, EP, et al.Purpose of quality standards for infectious diseases. Clin Infect Dis 1994;18:421.Google Scholar
10.Kritchevsky, SB, Simmons, BP. Toward better antibiotic use in hospitals. Infect Control Hosp Epidemiol 1994:15:688-690.CrossRefGoogle Scholar
11.Coronado, VG, Edwards, JR, Culver, DH, Gaynes, RP, National Nosocomial Infections Surveillance System. Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol 1995;16:000–000.CrossRefGoogle ScholarPubMed
12.Burwen, DR, Banejee, SN, Gaynes, RP, National Nosocomial Infections Surveillance System. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. J Infect Dis 1994;170:1622–1625.Google Scholar
13.Thornsbery, C.The epidemiology of emerging resistance. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy; October 4-7, 1994; Orlando, Florida.Google Scholar
14.McGowan, JE Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994;15:478-483.CrossRefGoogle Scholar
15.Austrian, R. Confronting drug-resistant pneumococci. Ann Intern Med 1994;121:807–809.CrossRefGoogle ScholarPubMed
16.John, CC. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin Infect Dis 1994;18:188–193.Google Scholar
17.Billstein, SAHow the pharmaceutical industry brings an antibiotic drug to market in the United States. Antimicrob Agents Chemother 1994;38:2679–2682.CrossRefGoogle ScholarPubMed
18.Blumberg, HM, Rimland, D, Carroll, DJ, Terry, P, Wachsmuth, IK. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis 1991;163:1279–1285.CrossRefGoogle ScholarPubMed
19.Kissick, WL. Medicine's Dilemmas-Infinite Needs Versus Finite Resources. New Haven, CT: Yale University Press, 1994: 185 pgs.Google Scholar
20.Girard, DE. The relationship between physicians in training and pharmaceutical companies. A time for guidelines? Arch Intern Med 1992;152:920–921.CrossRefGoogle ScholarPubMed
21.French, G, Percival, A. Debate: we are approaching the end of the antibiotic era. Presented at Challenges in Infection Control. November 17-18, 1994; London, England.Google Scholar
22.Culotta, E. Funding crunch hobbles antibiotic resistance research. Science 1994;264:362–363.Google Scholar